What is Tango Therapeutics's restricted cash?

Tango Therapeutics (TNGX) reported restricted cash of $0 in Q1 2026.

How has Tango Therapeutics's restricted cash changed year-over-year?

Tango Therapeutics's restricted cash decreased by 100.0% year-over-year, from $428K to $0.

What is the long-term trend for Tango Therapeutics's restricted cash?

Over 5 years (2020 to 2025), Tango Therapeutics's restricted cash has grown at a -28.4% compound annual growth rate (CAGR), from $2.28M to $428K.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Tango Therapeutics TNGX Restricted Cash

Restricted Cash at other companies

Cogent Biosciences, Inc.COGT

$416K—

Lantheus HoldingsLNTH

$1.71M+1.8%

Tempus AI, Inc.TEM

$4.69M+172%

Guardant HealthGH

$112.15M+6.5%

ImmunityBio, Inc.IBRX

——

Roivant SciencesROIV

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$48.8M-14.7%

Net income-$45.5M-14.1%

EPS (diluted)-$0.32+11.1%

Balance sheet

See full

Cash & equivalents$160.0M+162%

Total debt$32.8M-11.3%

Total equity$391.5M+135%

Total assets$435.8M+58.9%

Cash flow

See full

Operating cash flow-$44.4M-6.4%

CapEx-$2.0K-104%

Free cash flow-$44.4M-6.3%

Valuation

See full

Market cap$4.55B+1,915%

Enterprise value$4.43B+2,204%

P/S79.9×+74.4×

Profitability

See full

Operating margin-206.2%-61.0pp

Net margin-188.2%-55.4pp

FCF margin-250.1%-49.4pp

Returns & leverage

See full

Return on equity-38.4%-10.5pp

Debt / equity0.1×-0.1×

Current ratio27.4×+21.1×

Where this comes from

Reported directly by Tango Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.

The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tango Therapeutics's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tango Therapeutics's restricted cash?: Tango Therapeutics (TNGX) reported restricted cash of $0 in Q1 2026.
How has Tango Therapeutics's restricted cash changed year-over-year?: Tango Therapeutics's restricted cash decreased by 100.0% year-over-year, from $428K to $0.
What is the long-term trend for Tango Therapeutics's restricted cash?: Over 5 years (2020 to 2025), Tango Therapeutics's restricted cash has grown at a -28.4% compound annual growth rate (CAGR), from $2.28M to $428K.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.